FWM
BCAB icon

Frontier Wealth Management’s BioAtla BCAB Stock Holding History

Frontier Wealth Management’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$212K – 423
2021
Q2 		$212K Buy
+100
New +$226K 0.01% 399

Other funds holding BCAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Frontier Wealth Management's BCAB Position: Q3 2021 in Review

Frontier Wealth Management sold out of BioAtla (BCAB) in Q3 2021, closing a stake of 100 shares — an estimated $212K sold.

Frontier Wealth Management first reported a position in BCAB in Q2 2021 and held it in 1 quarter. The position peaked at $212K in Q2 2021. 86 funds tracked by Wall St. Rank hold BCAB as of Q3 2021.

  • Frontier Wealth Management reported no remaining BioAtla position as of Q3 2021 after selling out during the quarter.
  • Frontier Wealth Management sold 100 BioAtla shares in Q3 2021, an estimated $212K.
  • Frontier Wealth Management first reported a position in BioAtla in Q2 2021 and held it in 1 quarter.
  • Frontier Wealth Management's BioAtla position peaked at $212K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held BioAtla as of Q3 2021.

Based on Frontier Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.